Wellington Management Group LLP Vertex Pharmaceuticals Inc Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 4,798,870 shares of VRTX stock, worth $2.17 Billion. This represents 0.4% of its overall portfolio holdings.

Number of Shares

4,798,870

Previous 4,094,449 17.2%

Holding current value

$2.17 Billion

Previous $1.92 Billion 16.29%

% of portfolio

0.4%

Previous 0.35%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $324 Million - $356 Million	704,421 Added 17.2%	4,798,870 $2.23 Billion
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $182 Million - $225 Million	-463,784 Reduced 10.17%	4,094,449 $1.92 Billion
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $1.86 Billion - $2.03 Billion	4,558,233 New	4,558,233 $1.91 Billion
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $1.79 Billion - $2.15 Billion	5,228,538 New	5,228,538 $2.13 Billion
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $347 Million - $372 Million	-1,027,043 Reduced 13.6%	6,525,851 $2.27 Billion
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $11.1 Million - $12.4 Million	35,346 Added 0.47%	7,552,894 $2.66 Billion
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $195 Million - $223 Million	689,965 Added 10.11%	7,517,548 $2.37 Billion
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $343 Million - $386 Million	-1,201,759 Reduced 14.97%	6,827,583 $1.97 Billion
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $56.5 Million - $63 Million	-206,297 Reduced 2.5%	8,029,342 $2.32 Billion
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $42.7 Million - $53.2 Million	181,929 Added 2.26%	8,235,639 $2.32 Billion
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $340 Million - $401 Million	1,535,255 Added 23.55%	8,053,710 $2.1 Billion
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $75.6 Million - $95.5 Million	427,366 Added 7.02%	6,518,455 $1.43 Billion
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $400 Million - $448 Million	-2,204,600 Reduced 26.58%	6,091,089 $1.1 Billion
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $39.2 Million - $46.3 Million	209,325 Added 2.59%	8,295,689 $1.67 Billion
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $232 Million - $270 Million	-1,120,147 Reduced 12.17%	8,086,364 $1.74 Billion
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $625 Million - $834 Million	3,020,047 Added 48.82%	9,206,511 $2.18 Billion
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $70.4 Million - $83.5 Million	-275,346 Reduced 4.26%	6,186,464 $1.68 Billion
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $259 Million - $340 Million	-1,149,958 Reduced 15.11%	6,461,810 $1.88 Billion
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $35.1 Million - $43.5 Million	175,609 Added 2.36%	7,611,768 $1.81 Billion
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $1.24 Billion - $1.67 Billion	7,436,159 New	7,436,159 $1.63 Billion

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Vertex Pharmaceuticals Inc Transaction History